Product Images Atracurium Besylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Atracurium Besylate NDC 55150-216 by Auromedics Pharma Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a warning about a paralyzing agent drug called Besylate Injection. The drug must be refrigerated between 2° to 8°C (36° to 46°F) and should not be frozen. Upon removal from refrigeration, the drug should be used within 14 days even if re-refrigerated. The drug comes in a 5 mL sterile single-dose vial and is made in India by AUROMEDICS. Facilities must be available for artificial respiration as the drug causes respiratory arrest. The drug is sterile and non-pyrogenic.*
This is a description of a drug called Atracurium Besylate Injection. It comes in single-dose vials with 10mg/mL dosage. The drug is used for intravenous injection and is a paralyzing agent with a warning of respiratory distress. The drug comes with precautionary measures, and each vial contains 0.9 sk byt USP along with other chemicals. The drug needs to be refrigerated at a specific temperature to maintain efficacy.*
This text appears to be a label or instruction for a medication called Atracurium Besylate Injection, USP. The concentration of the medication is 10mg/mL and it is advised to peel off and apply to a syringe. The label also has fields for date and time, as well as a space for the name or initials of the person administering the medication.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.